Albaron Partners has closed its flagship fund, Albaron Healthcare Opportunities I, with $185 million in commitments. The fund exceeded its target, becoming oversubscribed as investors continue to show strong appetite for healthcare-focused private equity opportunities despite recent market volatility in other sectors.

Founded in 2017 and based in New York, Albaron operates as a lower middle market private equity firm targeting North American healthcare and healthcare services companies. The firm specifically targets businesses generating between $1 million and $10 million in EBITDA, positioning itself in an underserved segment of the healthcare investment landscape that larger private equity firms often overlook.

The oversubscribed fund signals continued investor confidence in healthcare services despite broader economic uncertainty. Albaron now has substantial capital to deploy in a market where smaller healthcare companies often struggle to attract institutional funding, potentially creating attractive returns as these businesses consolidate or scale operations. This particular focus on the lower middle market could provide Albaron with a competitive advantage as larger firms increasingly concentrate on larger deals.